Clinical Trials on Metastatic ER+ Breast Cancer in Australia
Total 670 results
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Hong Kong, Taiwan, Malaysia, Thailand, Argentina, Belgium, Portugal
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy...CompletedMetastatic Breast CancerAustralia
-
AstraZenecaCompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerBelgium, Canada, Austria, Australia
-
PharmAbcineMerck Sharp & Dohme LLCRecruitingMetastatic Triple-Negative Breast CancerAustralia
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedMetastatic Breast CancerFrance, Austria, Belgium, Australia, Italy
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Genor Biopharma Co., Ltd.Completed
-
Peter MacCallum Cancer Centre, AustraliaNovartis PharmaceuticalsCompletedMetastatic Breast CancerAustralia
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
Medical University of ViennaUnknownMetastatic Breast CancerAustria
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, Australia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
Neovii BiotechTerminatedAdvanced Breast Cancer | Metastatic Breast CancerSpain, Austria, France, Germany, Italy
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
CelgeneCompleted
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United Kingdom, Korea, Republic of, Australia, United States, Spain
-
SanofiCompletedBreast Cancer, MetastaticAustralia, Belgium, France, Italy, Netherlands, Spain
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Elisabethinen HospitalMedical University InnsbruckRecruiting
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticFrance, Germany, Spain, Austria, Belgium, Slovenia, Poland, Bulgaria, United Kingdom, Italy
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
Ambrx, Inc.RecruitingHER2 Positive Metastatic Breast CancerUnited States, Korea, Republic of, France, Australia
-
R-PharmCompletedMetastatic Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast CancerCzech Republic, Italy, Poland, Spain, Austria, France, Greece
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, United Kingdom, Poland, Taiwan, Colombia, Turkey, Germany, Italy
-
BayerCompletedMetastatic Breast CancerSpain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
-
Eisai Inc.CompletedMetastatic Breast CancerPoland, Ukraine, United States, Taiwan, Spain, Argentina, Bulgaria, Romania, South Africa, Australia, Canada, Singapore, Russian Federation, Brazil, Germany, Hungary, Italy, Israel, Greece, Mexico, Belgium, Czechia, France
-
SanofiActive, not recruitingBreast Cancer MetastaticKorea, Republic of, Belgium, Taiwan, China, France, United States, Argentina, Australia, Brazil, Canada, Czechia, Greece, Israel, Italy, Japan, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey, Ukraine
-
Novartis PharmaceuticalsCompletedAdvanced, Metastatic Breast CancerUnited States, Canada, France, Italy, Spain, Taiwan, Hungary, Turkey, Belgium, Germany, Netherlands, Singapore, Austria, Czechia, Australia, Israel, Russian Federation, Sweden, United Kingdom, Korea, Republic of, Thailand, Lebanon, ... and more
-
PharmAbcineActive, not recruitingTriple Negative Breast CancerAustralia
-
TakedaTakeda Development Center Americas, Inc.RecruitingUnresectable Locally Advanced or Metastatic CancerSpain, United States, Australia, Canada
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Finland, France, Hungary, Israel, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom